- You can view the full Bristol-Myers Squibb Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
This drug stock has stumbled on a failed clinical trial, but here's why the stock is a bargain right now.
A quick-turning reversal pattern is all that is needed to set things in motion.
Cramer says Bristol-Myers is the value stock to own and Foot Locker is doing as well as he predicted.
Demand is quite healthy and markets are not going into the abyss, Cramer says.